Is sustained pharmacologic lung volume reduction now possible in COPD?

Chest. 2006 Mar;129(3):501-3. doi: 10.1378/chest.129.3.501.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Bronchodilator Agents / therapeutic use*
  • Drug Therapy, Combination
  • Ethanolamines / therapeutic use*
  • Forced Expiratory Volume
  • Formoterol Fumarate
  • Humans
  • Inspiratory Capacity
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Scopolamine Derivatives / therapeutic use*
  • Tiotropium Bromide

Substances

  • Bronchodilator Agents
  • Ethanolamines
  • Scopolamine Derivatives
  • Formoterol Fumarate
  • Tiotropium Bromide